By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
MARKET CLOSE: NZ shares bounce, Port of Tauranga and Scales up while Comvita declines
Mercer says collapsed Fonterra silo could cost as much as $45 mln
Bank margins to remain under pressure as mortgage market stays competitive, BNZ's Healy says
NZ dollar falls vs. yuan on concern over Chinese devaluation
Fonterra raises Australian farmgate milk price in response to stronger global dairy prices
Fugitive Simon Turnbull pleads guilty to mortgage fraud
NZ Oil & Gas expects to make leadership announcement 'in coming days'
Wynyard administration prompts shareholders to join class action
Harmos Horton Lusk director Starrenburg named to Takeovers Panel for 5-year term
NZ trade deficit widens to a record in September as meat exports fall